After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, ...
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
From singing on Broadway to playing beloved characters on the big screen (including everyone's favorite animated snowman, ...
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...
Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...
New research shows that extreme weight loss and weight gain significantly increase the risk of death in obese individuals with cardiovascular disease.
To the person who continues to comment about our bad experience at the Plant City Strawberry Festival, you didn’t pay $85 for ...
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...